세계의 실험실 자동화 시장 - 규모, 점유율, 동향 분석 보고서 : 프로세스별, 자동화 유형별, 최종 용도별, 지역별 부문 예측(2025-2033년)

Lab Automation Market Size, Share & Trends Analysis Report By Process, By Automation Type, By End-use, By Region, And Segment Forecasts, 2025 - 2033

US $ 5,950 ￦ 8,861,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,350,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 13,329,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

실험실 자동화 시장 요약

세계의 실험실 자동화 시장 규모는 2024년 82억 7,000만 달러로, 2033년까지 183억 9,000만 달러에 이를 것으로 예측됩니다.

2025년부터 2033년까지 연평균 복합 성장률(CAGR) 9.3%로 성장할 전망입니다. 시장 성장은 첨단 스크리닝에 대한 수요 증가, 실험실 효율화 및 세계 첨단 자동화 솔루션의 도입으로 인한 것입니다.

비용과 시간의 효율성

비용과 시간의 효율성은 세계의 실험실 자동화 시장에 영향을 미치는 주요 요소입니다. 생명공학, 제약, 임상 분야 연구소에서는 생산성 향상, 수작업 절감, 프로세스 간소화를 위해 자동화 기술의 사용이 점차 증가하고 있습니다. 자동화 장비는 피펫팅, 샘플 준비 및 데이터 분석과 같은 반복적이고 시간이 많이 소요되는 작업을 수동 방식보다 정확하고 신속하게 완료할 수 있습니다. 이를 통해 연구자가 실험 설계 및 데이터 분석과 같은 고부가가치 업무에 집중할 수 있어 워크플로우 효율성과 과학적 성과 향상에 기여합니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장의 변수, 동향, 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 보조 시장 전망
• 시장 동향과 전망
• 시장 역학
  • 시장 성장 촉진요인의 영향 분석
  • 시장 성장 억제요인의 영향 분석
• 비즈니스 환경 분석
  • PESTLE 분석
  • Porter's Five Forces 분석

제4장 프로세스별 비즈니스 분석

• 프로세스 부문 대시보드
• 세계의 실험실 자동화 시장 : 프로세스별 변동 분석
• 세계의 실험실 자동화 시장 규모와 동향 분석(프로세스별, 2021-2033년)
• 연속 흐름
  • 워크플로우별
  • 컴포넌트별
• 이산 처리
  • 방법별
  • 컴포넌트별
  • 워크플로우별

제5장 자동화 유형별 비즈니스 분석

• 자동화 유형 부문 대시보드
• 세계의 실험실 자동화 시장 : 자동화 유형별 변동 분석
• 세계의 실험실 자동화 시장 규모와 동향 분석(자동화 유형별, 2021-2033년)
• 총 자동화
  • 스텝별
• 모듈러 자동화 시스템
  • 스텝별

제6장 최종 용도별 비즈니스 분석

• 최종 용도 부문 대시보드
• 세계의 실험실 자동화 시장 : 최종 용도별 변동 분석
• 세계의 실험실 자동화 시장 규모와 동향 분석(최종 용도별, 2021-2033년)
• 임상 화학 분석
• 측광법 및 형광법
• 면역 측정 분석
• 전해질 분석
• 기타

제7장 실험실 자동화 시장 : 프로세스, 자동화 유형, 최종 용도별 지역 추정 및 동향 분석

• 지역 대시보드
• 시장 규모와 예측 및 동향 분석, 2024-2033년
• 북미
  • 북미의 실험실 자동화 시장, 2021-2033년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 유럽의 실험실 자동화 시장, 2021-2033년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 아시아태평양의 실험실 자동화 시장, 2021-2033년
  • 일본
  • 중국
  • 인도
  • 싱가포르
  • 호주
  • 태국
  • 한국
• 라틴아메리카
  • 라틴아메리카의 실험실 자동화 시장, 2021-2033년
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 중동 및 아프리카의 실험실 자동화 시장, 2021-2033년
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 기업 분류
• 전략 매핑
• 기업시장 포지셔닝 분석, 2024년
• 기업 프로파일
  • QIAGEN
  • PerkinElmer Inc.
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthcare GmbH
  • Danaher
  • Agilent Technologies, Inc.
  • Eppendorf SE
  • Hudson Robotics
  • Aurora Biomed Inc.
  • BMG LABTECH GmbH
  • F. Hoffmann-La Roche Ltd

JHS

영문 목차

영문목차

Lab Automation Market Summary

The global lab automation market size was estimated at USD 8.27 billion in 2024 and is projected to reach USD 18.39 billion by 2033, growing at a CAGR of 9.3% from 2025 to 2033. The market growth is driven by rising demand for advanced screening, laboratory efficiency, and the adoption of advanced automated solutions globally.

Cost & Time Efficiency

Cost and time efficiency are major factors influencing the global lab automation market. Automation technologies are increasingly being used by laboratories in the biotechnology, pharmaceutical, and clinical sectors to improve productivity, reduce manual intervention, and streamline processes. Automated instruments can more accurately and quickly complete repetitive and time-consuming tasks such as pipetting, sample preparation, and data analysis than manual methods. This helps to enhance the workflow effectiveness and scientific output by freeing researchers to concentrate on higher-value tasks such as experimental design and data interpretation.

Global Lab Automation Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global lab automation market based on process, automation type, end-use, and region:

• Process Outlook (Revenue, USD Million, 2021 - 2033)
• Continuous Flow
  • By Workflow
• Sequential Processing
• Parallel Processing
  • By Components
• Consumables
• Equipment
• Discrete Processing
  • By Method
• Centrifugal Discrete Processing
• Random Access Discrete Processing
  • By Components
• Consumables
• Equipment
  • By Workflow
• Dependent Analysis
• Independent Analysis
• Automation Type Outlook (Revenue, USD Million, 2021 - 2033)
• Total Automation
  • By Steps
• Pre-analysis
  • Centrifugation
  • Sample Preparation
  • Sample Sorting
• Transport Mechanisms
• Liquid Handling
• Sample Storage
• Sample Analysis
• Modular Automation Systems
  • By Steps
• Specimen Acquisition & Identification & Labelling
• Transport Mechanisms
• Sample Preparation
• Sample Loading & Aspiration
• Reagent Handling & Storage
• Sample Analysis & Measurements
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Clinical Chemistry Analysis
• Photometry & Fluorometry
• Immunoassay Analysis
• Electrolyte Analysis
• Other
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Process
  • 1.2.2. Automation Type
  • 1.2.3. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Impact Analysis
    • 3.3.1.1. Cost & time efficiency
    • 3.3.1.2. High-throughput screening needs
  • 3.3.2. Market Restraint Impact Analysis
    • 3.3.2.1. High costs
    • 3.3.2.2. Workforce and operational limitations
• 3.4. Business Environment Analysis
  • 3.4.1. PESTLE Analysis
  • 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Process Business Analysis

• 4.1. Process Segment Dashboard
• 4.2. Global Lab Automation Market Process, Movement Analysis
• 4.3. Global Lab Automation Market Size & Trend Analysis, by Process, 2021 to 2033 (USD Million)
• 4.4. Continuous Flow
  • 4.4.1. Global continuous flow market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. By Workflow
    • 4.4.2.1. Global workflow market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.1.1. Sequential Processing
        • 4.4.2.1.1.1. Global sequential processing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.1.2. Parallel Processing
        • 4.4.2.1.2.1. Global parallel processing market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. By Components
    • 4.4.3.1. Global components market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.1.1. Consumables
        • 4.4.3.1.1.1. Global consumables market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.1.2. Equipment
        • 4.4.3.1.2.1. Global equipment market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Discrete Processing
  • 4.5.1. Global discrete processing market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. By Method
    • 4.5.2.1. Global method market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.1.1. Centrifugal Discrete Processing
        • 4.5.2.1.1.1. Global centrifugal discrete processing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.1.2. Random Access Discrete Processing
        • 4.5.2.1.2.1. Global random access discrete processing market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. By Components
    • 4.5.3.1. Global components market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.1.1. Consumables
        • 4.5.3.1.1.1. Global consumables market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.1.2. Equipment
        • 4.5.3.1.2.1. Global equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.4. By Workflow
    • 4.5.4.1. Global workflow market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.4.1.1. Dependent Analysis
        • 4.5.4.1.1.1. Global dependent analysis market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.4.1.2. Independent Analysis
        • 4.5.4.1.2.1. Global independent analysis market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Automation Type Business Analysis

• 5.1. Automation Type Segment Dashboard
• 5.2. Global Lab Automation Market Automation Type, Movement Analysis
• 5.3. Global Lab Automation Market Size & Trend Analysis, by Automation Type, 2021 to 2033 (USD Million)
• 5.4. Total Automation
  • 5.4.1. Global total automation market estimates and forecasts, 2021 - 2033 (USD million)
  • 5.4.2. By Steps
    • 5.4.2.1. Global steps market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.4.2.1.1. Pre-analysis
        • 5.4.2.1.1.1. Global pre-analysis market estimates and forecasts, 2021 - 2033 (USD Million)
          • 5.4.2.1.1.1.1. Centrifugation
            • 5.4.2.1.1.1.1.1. Global centrifugation market estimates and forecasts, 2021 - 2033 (USD Million)
          • 5.4.2.1.1.1.2. Sample Preparation
            • 5.4.2.1.1.1.2.1. Global sample preparation market estimates and forecasts, 2021 - 2033 (USD Million)
          • 5.4.2.1.1.1.3. Sample Sorting
            • 5.4.2.1.1.1.3.1. Global sample sorting market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.4.2.1.2. Transport Mechanisms
        • 5.4.2.1.2.1. Global transport mechanisms market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.4.2.1.3. Liquid Handling
        • 5.4.2.1.3.1. Global liquid handling market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.4.2.1.4. Sample Storage
        • 5.4.2.1.4.1. Global sample storage market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.4.2.1.5. Sample Analysis
        • 5.4.2.1.5.1. Global sample analysis market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Modular Automation Systems
  • 5.5.1. Global modular automation systems market estimates and forecasts, 2021 - 2033 (USD million)
  • 5.5.2. By Steps
    • 5.5.2.1. Global steps market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.1.1. Specimen Acquisition & Identification & Labelling
        • 5.5.2.1.1.1. Global specimen acquisition & identification & labelling market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.1.2. Transport Mechanisms
        • 5.5.2.1.2.1. Global transport mechanisms market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.1.3. Sample Preparation
        • 5.5.2.1.3.1. Global sample preparation market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.1.4. Sample Loading & Aspiration
        • 5.5.2.1.4.1. Global sample loading & aspiration market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.1.5. Reagent Handling & Storage
        • 5.5.2.1.5.1. Global reagent handling & storage market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.1.6. Sample Analysis & Measurements
        • 5.5.2.1.6.1. Global sample analysis & measurements market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

• 6.1. End Use Segment Dashboard
• 6.2. Global Lab Automation Market End Use, Movement Analysis
• 6.3. Global Lab Automation Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Clinical Chemistry Analysis
  • 6.4.1. Global clinical chemistry analysis market estimates and forecasts, 2021 - 2033 (USD million)
• 6.5. Photometry & Fluorometry
  • 6.5.1. Global photometry & fluorometry market estimates and forecasts, 2021 - 2033 (USD million)
• 6.6. Immunoassay Analysis
  • 6.6.1. Global immunoassay analysis market estimates and forecasts, 2021 - 2033 (USD million)
• 6.7. Electrolyte Analysis
  • 6.7.1. Global electrolyte analysis market estimates and forecasts, 2021 - 2033 (USD million)
• 6.8. Other
  • 6.8.1. Global other market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 7. Lab Automation Market: Regional Estimates and Trend Analysis, by Process, Automation Type, & End-Use

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2024 to 2033
• 7.3. North America
  • 7.3.1. North America lab automation market, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Target Disease Prevalence
    • 7.3.2.3. Competitive Scenario
    • 7.3.2.4. Regulatory Framework
    • 7.3.2.5. U.S. lab automation market, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Target Disease Prevalence
    • 7.3.3.3. Competitive Scenario
    • 7.3.3.4. Regulatory Framework
    • 7.3.3.5. Canada lab automation market, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Target Disease Prevalence
    • 7.3.4.3. Competitive Scenario
    • 7.3.4.4. Regulatory Framework
    • 7.3.4.5. Mexico lab automation market, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe lab automation market, 2021 - 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Target Disease Prevalence
    • 7.4.2.3. Competitive Scenario
    • 7.4.2.4. Regulatory Framework
    • 7.4.2.5. UK lab automation market, 2021 - 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Target Disease Prevalence
    • 7.4.3.3. Competitive Scenario
    • 7.4.3.4. Regulatory Framework
    • 7.4.3.5. Germany lab automation market, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Target Disease Prevalence
    • 7.4.4.3. Competitive Scenario
    • 7.4.4.4. Regulatory Framework
    • 7.4.4.5. France lab automation market, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Target Disease Prevalence
    • 7.4.5.3. Competitive Scenario
    • 7.4.5.4. Regulatory Framework
    • 7.4.5.5. Italy lab automation market, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Target Disease Prevalence
    • 7.4.6.3. Competitive Scenario
    • 7.4.6.4. Regulatory Framework
    • 7.4.6.5. Spain lab automation market, 2021 - 2033 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Target Disease Prevalence
    • 7.4.7.3. Competitive Scenario
    • 7.4.7.4. Regulatory Framework
    • 7.4.7.5. Denmark lab automation market, 2021 - 2033 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Target Disease Prevalence
    • 7.4.8.3. Competitive Scenario
    • 7.4.8.4. Regulatory Framework
    • 7.4.8.5. Sweden lab automation market, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Target Disease Prevalence
    • 7.4.9.3. Competitive Scenario
    • 7.4.9.4. Regulatory Framework
    • 7.4.9.5. Norway lab automation market, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific lab automation market, 2021 - 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Target Disease Prevalence
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. Regulatory Framework
    • 7.5.2.5. Japan lab automation market, 2021 - 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Target Disease Prevalence
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Regulatory Framework
    • 7.5.3.5. China lab automation market, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Target Disease Prevalence
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Regulatory Framework
    • 7.5.4.5. India lab automation market, 2021 - 2033 (USD Million)
  • 7.5.5. Singapore
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Target Disease Prevalence
    • 7.5.5.3. Competitive Scenario
    • 7.5.5.4. Regulatory Framework
    • 7.5.5.5. Singapore lab automation market, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Target Disease Prevalence
    • 7.5.6.3. Competitive Scenario
    • 7.5.6.4. Regulatory Framework
    • 7.5.6.5. Australia lab automation market, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Target Disease Prevalence
    • 7.5.7.3. Competitive Scenario
    • 7.5.7.4. Regulatory Framework
    • 7.5.7.5. Thailand lab automation market, 2021 - 2033 (USD Million)
  • 7.5.8. South Korea
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Target Disease Prevalence
    • 7.5.8.3. Competitive Scenario
    • 7.5.8.4. Regulatory Framework
    • 7.5.8.5. South Korea lab automation market, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America lab automation market, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Target Disease Prevalence
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. Regulatory Framework
    • 7.6.2.5. Brazil lab automation market, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Target Disease Prevalence
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Regulatory Framework
    • 7.6.3.5. Argentina lab automation market, 2021 - 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA lab automation market, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Target Disease Prevalence
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. Regulatory Framework
    • 7.7.2.5. South Africa lab automation market, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Target Disease Prevalence
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. Regulatory Framework
    • 7.7.3.5. Saudi Arabia lab automation market, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Target Disease Prevalence
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Regulatory Framework
    • 7.7.4.5. UAE lab automation market, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Target Disease Prevalence
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. Regulatory Framework
    • 7.7.5.5. Kuwait lab automation market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. QIAGEN
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Process Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. PerkinElmer Inc.
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Process Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Thermo Fisher Scientific, Inc.
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Process Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Siemens Healthcare GmbH
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Process Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Danaher
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Process Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Agilent Technologies, Inc.
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Process Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. Eppendorf SE
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Process Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. Hudson Robotics
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Process Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. Aurora Biomed Inc.
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Process Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. BMG LABTECH GmbH
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Process Benchmarking
    • 8.4.10.4. Strategic Initiatives
  • 8.4.11. F. Hoffmann-La Roche Ltd
    • 8.4.11.1. Overview
    • 8.4.11.2. Financial Performance
    • 8.4.11.3. Process Benchmarking
    • 8.4.11.4. Strategic Initiatives

관련자료